Issuer · CIK 0000886163
LGND — LIGAND PHARMACEUTICALS INC
⚡ SELL CLUSTER · last 7 days
2 insiders sold $1.4M of $LGND between Jun 16, 2026 and Jun 18, 2026.
Cluster patterns historically carry stronger directional signal than any single insider trade. Read the methodology →
Sabba Stephen L
director
$544.8K
Jun 18, 2026
Haas Jason
director
$886.3K
Jun 16, 2026
Recent filings
- Jun 18, 2026·Form 4·Sell$544.8K
LGND/LIGAND PHARMACEUTICALS INC
Sabba Stephen L · director
8conviction - Jun 16, 2026·Form 4·Sell$886.3K
LGND/LIGAND PHARMACEUTICALS INC
Haas Jason · director
12conviction - Jun 12, 2026·Form 4·Sell$1.1M
LGND/LIGAND PHARMACEUTICALS INC
Aryeh Jason · director
22conviction - Jun 12, 2026·Form 4·Sell$856.8K
LGND/LIGAND PHARMACEUTICALS INC
LAMATTINA JOHN L · director
28conviction - Jun 9, 2026·Form 4·Other$43.1K
LGND/LIGAND PHARMACEUTICALS INC
Zimmermann Martine · director
Mechanical filing
AI thesis skipped - Jun 9, 2026·Form 4·Other$0
LGND/LIGAND PHARMACEUTICALS INC
Sabba Stephen L · director
Mechanical filing
AI thesis skipped - Jun 9, 2026·Form 4·Other$0
LGND/LIGAND PHARMACEUTICALS INC
LAMATTINA JOHN L · director
Mechanical filing
AI thesis skipped - Jun 9, 2026·Form 4·Other$0
LGND/LIGAND PHARMACEUTICALS INC
KOZARICH JOHN W · director
Mechanical filing
AI thesis skipped - Jun 9, 2026·Form 4·Other$0
LGND/LIGAND PHARMACEUTICALS INC
Haas Jason · director
Mechanical filing
AI thesis skipped - Jun 9, 2026·Form 4·Other$0
LGND/LIGAND PHARMACEUTICALS INC
Gray Nancy Ryan · director
Mechanical filing
AI thesis skipped - Jun 2, 2026·Form 4·Sell$323.6K
LGND/LIGAND PHARMACEUTICALS INC
Reardon Andrew · CLO & Secretary
8conviction - May 28, 2026·Form 4·Other$51.4K
LGND/LIGAND PHARMACEUTICALS INC
Espinoza Octavio · Chief Financial Officer
Mechanical filing
AI thesis skipped - May 15, 2026·Form 4·Sell$352K
LGND/LIGAND PHARMACEUTICALS INC
KOZARICH JOHN W · director
8conviction - May 5, 2026·Form 4·Sell$330.7K
LGND/LIGAND PHARMACEUTICALS INC
Reardon Andrew · CLO & Secretary
8conviction